New biosensor shows robust detection of CaMKII activity in HeLa cells and neurons, suggesting insights into calcium signaling.
Accurately monitoring calcium/calmodulin-dependent protein kinase II (CaMKII) activity in cells remains a significant challenge due to the limited sensitivity and narrow dynamic range of existing genetically encoded sensors. Here, we introduce CaMK2rep, a novel phosphorylation-based biosensor that enables robust, specific, and high-sensitivity detection of CaMKII activity. CaMK2rep is designed with two tandem CaMKII consensus sites embedded within the native sequence context of synapsin, and its phosphorylation is detected via a phospho-specific antibody, allowing both biochemical and morphological analyses. We validated CaMK2rep in HeLa cells and cultured hippocampal neurons, demonstrating a near-linear response to CaMKII expression levels and to stimulation intensity, and no detectable cytotoxicity. To complement CaMK2rep measurements, we employed the live-cell CaMKAR (Reyes Gaido, O. E. et al. Sci. Transl. Med. 15, eabq7839 (2023)) reporter to monitor CaMKII activity dynamics. Using both tools, we investigated the role of neurogranin (Ng), a major postsynaptic calmodulin (CaM) binding protein, and obtained consistent evidence supporting a CaM-buffering model in which Ng limits basal CaMKII activation by sequestering CaM. These findings establish CaMK2rep as a sensitive, specific, and versatile biosensor for CaMKII signaling, particularly well-suited for immunoblot-based population analyses. They also illustrate the value of combining orthogonal genetically encoded tools to interrogate complex signaling mechanisms in both physiological and pathological contexts.
No takes yet. Share an insight, caveat, or question.
Martínez‐Blanco et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: